26th Feb 2014 12:22
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
GlaxoSmithKline Deferred Annual Bonus Plan
Withholding of shares to meet tax liabilities
The table below sets out changes in the interests of an Executive Director and PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value of $55.69 per ADS to meet tax liabilities following the vesting of the pre-tax awards granted under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (DABP). The awards vested on the third anniversary of the award date which was 24 February 2014.
Number of ADSs withheld to meet tax liabilities following the vesting of a DABP award | |
Dr M Slaoui* | 13,774 |
Ms D Connelly | 1,991 |
Mr D Troy | 5,183 |
* Denotes an Executive Director
The Company, the Executive Director and PDMRs were advised of these transactions on 25 February 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Sonja Arsenić
Corporate Secretariat
26 February 2014
Related Shares:
Glaxosmithkline